| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$206 |
Appendix 3Y - Michael McNulty
|
31 Oct 2025 9:03AM |
$1.135 |
$0.755 |
fallen by
33.48%
|
|
| Perennial Income Generator Fund (Managed Fund) (EIGA) |
Financials |
$27 |
EIGA Monthly Portfolio Disclosure
|
31 Oct 2025 9:03AM |
$3.760 |
$3.820 |
risen by
1.60%
|
|
| Kuniko Limited (KNI) ORDINARY FULLY PAID |
Materials |
$7 |
Airborne Geophysics Underway at Commonwealth Project
|
31 Oct 2025 9:03AM |
$0.066 |
$0.027 |
fallen by
59.09%
|
|
KNI - Price-sensitive ASX Announcement
Full Release
Key Points
- 328 line-kilometre MobileMT survey to map sulphide zones.
- Advanced electromagnetic imaging for 3D resistivity modelling.
- Geophysical program focuses on the Commonwealth-Silica Hill corridor.
- Community coordination with local landholders for low-impact data acquisition.
- Kuniko is focused on ethical sourcing and energy transition minerals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| eInvest Better Future (Managed Fund) (IMPQ) |
Financials |
$24 |
IMPQ Monthly Portfolio Disclosure
|
31 Oct 2025 9:02AM |
$5.090 |
$4.160 |
fallen by
18.27%
|
|
| Jindalee Lithium Limited (JLL) ORDINARY FULLY PAID |
Materials |
$44 |
Quarterly Cashflow Report - September 2025
|
31 Oct 2025 9:01AM |
$0.545 |
$0.345 |
fallen by
36.70%
|
|
JLL - Price-sensitive ASX Announcement
Full Release
Key Points
- Negative cash flows from operating and investing activities.
- Net cash used in operating activities was AUD 1,024,000.
- Net cash used in investing activities was AUD 861,000.
- Cash and cash equivalents at end of period were AUD 2,099,000.
- Recent AUD 8 million raised through share placement.
- Company remains optimistic about meeting business objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Jindalee Lithium Limited (JLL) ORDINARY FULLY PAID |
Materials |
$44 |
Quarterly Activities Report - September 2025
|
31 Oct 2025 9:01AM |
$0.545 |
$0.345 |
fallen by
36.70%
|
|
JLL - Price-sensitive ASX Announcement
Full Release
Key Points
- McDermitt Lithium Project designated as a FAST-41 Transparency Project.
- Non-binding LOI with SPAC to raise US$20-30M, listing on a US exchange.
- Value optimization program for magnesium by-products at McDermitt.
- US government support and strategic partnerships being pursued.
- Capital raising of $8 million and proposed equity line of credit of up to US$100M.
- Appointment of Tristan Garthe as Chief Financial Officer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Polymetals Resources Ltd (POL) ORDINARY FULLY PAID |
Materials |
$313 |
Reinstatement to Quotation
|
31 Oct 2025 9:01AM |
$1.245 |
$1.015 |
fallen by
18.47%
|
|
POL - Price-sensitive ASX Announcement
Full Release
Key Points
- Polymetals Resources Ltd (ASX: POL) will have its trading suspension lifted.
- The reinstatement follows an announcement regarding a serious safety incident at the Endeavor Mine Site.
- ASX Compliance issued the announcement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Gold and Copper Ltd (AGC) ORDINARY FULLY PAID |
Materials |
$41 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 9:01AM |
$0.180 |
$0.125 |
fallen by
30.56%
|
|
AGC - Price-sensitive ASX Announcement
Full Release
Key Points
- AGC executed a binding tenement sale agreement for Browns Reef Project.
- The Browns Reef Project adds 1,269km² to AGC's existing South Cobar holdings.
- AGC conducted aircore and RC drilling, with promising assay results.
- Significant mineralization discovered at Achilles Shear Zone.
- Company remains well-funded with $12.5M cash on-hand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Polymetals Resources Ltd (POL) ORDINARY FULLY PAID |
Materials |
$313 |
Significant Incident Endeavor Mine
|
31 Oct 2025 9:01AM |
$1.245 |
$1.015 |
fallen by
18.47%
|
|
POL - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant incident at the Endeavor Mine involving fatalities.
- Immediate suspension of all operations at the site.
- Investigation into the cause of the incident is ongoing.
- Support extended to affected families and colleagues.
- Planned staged resumption of operations starting 5 November 2025.
- Polymetals' commitment to safety and well-being as a priority.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Visionflex Group Limited (VFX) ORDINARY FULLY PAID |
Health Care |
$5 |
Appendix 4C - Q1 FY26
|
31 Oct 2025 9:00AM |
$0.002 |
$0.055 |
risen by
2,650%
|
|
VFX - Price-sensitive ASX Announcement
Full Release
Key Points
- Visionflex Group Limited reported a net cash outflow from operating activities of $999,000 for the quarter ending on 30 September 2025.
- The company made payments for staff wages amounting to $927,000 and incurred $546,000 in product manufacturing and operating costs.
- Visionflex Group utilized $540,000 from convertible debt securities, with transaction costs of $22,000 related to these financings.
- Cash and cash equivalents at the end of the quarter stood at $1,402,000, maintaining the same balance as the previous quarter.
- The company has a credit standby arrangement of $4,000,000, with $3,000,000 currently drawn down.
- Visionflex is converting $3 million of the facility and $0.25 million of accrued interest into equity, subject to shareholder approval.
- Key financing terms include an interest rate of 11.10% per annum and a line fee of 1% per annum, with provisions for conversion into shares.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Peoplein Limited (PPE) ORDINARY FULLY PAID |
Industrials |
$76 |
Update - Notification of buy-back - PPE
|
31 Oct 2025 9:00AM |
$0.850 |
$0.690 |
fallen by
18.82%
|
|
| TALI Digital Limited (TD1) ORDINARY FULLY PAID |
Health Care |
$4 |
Proposed issue of securities - TD1
|
31 Oct 2025 9:00AM |
$0.001 |
$0.090 |
risen by
8,900%
|
|
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$4,977 |
Update - Notification of buy-back - WOR
|
31 Oct 2025 9:00AM |
$14.360 |
$10.205 |
fallen by
28.93%
|
|
| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Proposed issue of securities - EXL
|
31 Oct 2025 8:59AM |
$0.015 |
$0.007 |
fallen by
53.33%
|
|
| Aspermont Limited (ASP) ORDINARY FULLY PAID |
Communication Services |
$14 |
Aspermont Q4 FY25 Trading Update
|
31 Oct 2025 8:59AM |
$0.008 |
$1.150 |
risen by
14,275%
|
|
ASP - Price-sensitive ASX Announcement
Full Release
Key Points
- Aspermont Limited reported a Q4 FY25 trading update, highlighting a 5% year-on-year increase in total revenue to $4.7 million.
- The company achieved $11.2 million in Annual Recurring Revenue, marking the 37th consecutive quarter of subscription revenue growth.
- An initial enterprise data contract was secured with Rio Tinto worth approximately $550,000.
- The launch of Mining-IQ v1, a new proprietary data and intelligence platform, occurred in August 2025.
- The balance sheet was strengthened by a $1.75 million institutional placement and a $1.03 million Share Purchase Plan.
- The events division saw a 20% increase in attendees at the Future of Mining Australia event.
- Net cash at the end of the quarter was reported at $2.9 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$206 |
Appendix 3Y - John Van Der Wielen
|
31 Oct 2025 8:59AM |
$1.135 |
$0.755 |
fallen by
33.48%
|
|
| TALI Digital Limited (TD1) ORDINARY FULLY PAID |
Health Care |
$4 |
Consolidation/Split - TD1
|
31 Oct 2025 8:59AM |
$0.001 |
$0.090 |
risen by
8,900%
|
|
| Woolworths Group Limited (WOW) ORDINARY FULLY PAID |
Consumer Staple |
$47,752 |
Appendix 3Z - Holly Kramer
|
31 Oct 2025 8:59AM |
$28.530 |
$39.090 |
risen by
37.01%
|
|
| Atomo Diagnostics Limited (AT1) ORDINARY FULLY PAID |
Health Care |
$15 |
2025 Annual General Meeting - MD & CEO Address
|
31 Oct 2025 8:59AM |
$0.028 |
$0.017 |
fallen by
39.29%
|
|
| Top End Energy Limited (TEE) ORDINARY FULLY PAID |
Energy |
$10 |
Appendix 5B
|
31 Oct 2025 8:58AM |
$0.039 |
$0.037 |
fallen by
5.13%
|
|
TEE - Price-sensitive ASX Announcement
Full Release
Key Points
- Top End Energy Limited's quarterly cash flow report for the period ending 30 September 2025.
- Net cash flow from operating activities was negative, at AUD 598,000.
- Cash flow from investing activities was also negative, at AUD 665,000.
- No cash flow from financing activities was reported for the quarter.
- Cash and cash equivalents at the end of the period were AUD 2,554,000.
- Payments to related parties totaled AUD 105,000, comprising director fees.
- The company has an estimated 2.02 quarters of funding available based on current cash flow and expenditure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Solis Minerals Ltd (SLM) ORDINARY FULLY PAID |
Materials |
$24 |
Quarterly Activities Report
|
31 Oct 2025 8:58AM |
$0.051 |
$0.072 |
risen by
41.18%
|
|
SLM - Price-sensitive ASX Announcement
Full Release
Key Points
- Active exploration in Peru with drilling at Chancho al Palo and Ilo Este.
- Successful acquisition of Cucho Copper Project to expand portfolio.
- Completion of geophysical survey at Cinto project.
- Voluntary delisting from TSX Venture Exchange.
- Raising of $5.9 million through a placement for exploration funding.
- Change of financial year-end to align with Australian standards.
- Appointment of a new Chief Financial Officer and a Non-Executive Director.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clearview Wealth Limited (CVW) ORDINARY FULLY PAID |
Financials |
$417 |
Update - Notification of buy-back - CVW
|
31 Oct 2025 8:58AM |
$0.605 |
$0.650 |
risen by
7.44%
|
|
| Contact Energy Limited (CEN) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Utilities |
$7,783 |
D & O Ongoing disclosure
|
31 Oct 2025 8:57AM |
$8.330 |
$7.270 |
fallen by
12.73%
|
|
| Percheron Therapeutics Limited (PER) ORDINARY FULLY PAID |
Health Care |
$8 |
Quarterly Activities Report and Appendix 4C
|
31 Oct 2025 8:57AM |
$0.008 |
$0.005 |
fallen by
37.50%
|
|
PER - Price-sensitive ASX Announcement
Full Release
Key Points
- Percheron Therapeutics Limited reported positive clinical data from the phase I clinical trial of HMBD-002.
- HMBD-002 showed a favorable safety profile and potential efficacy in certain cancer patients.
- Preclinical data for HMBD-002 was positive in triple-negative breast cancer and squamous cell carcinoma of the head and neck.
- Percheron plans a multi-arm phase II clinical trial for HMBD-002 to start in CY2026.
- Financial expenditures included $1.93 million for R&D and $3.07 million for investing activities.
- The company received an R&D Tax Incentive rebate of $1.43 million.
- Percheron launched an interactive investor hub to engage with stakeholders.
- Cash balance at the end of the quarter was $5.68 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$65 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 8:57AM |
$0.295 |
$0.275 |
fallen by
6.78%
|
|
M7T - Price-sensitive ASX Announcement
Full Release
Key Points
- Decrease in cash receipts by 27% compared to Q1 FY25.
- Cash position strong with A$18.9M and no debt.
- Operating cash outflows were A$3.7M.
- Capitalized A$0.3M in development costs for an R&D project.
- First phase of VHA NTP project go-live with potential A$11.7M contract value.
- Ongoing efforts to achieve MDR compliance.
- Leadership changes and strategic review in process.
- Share buy-back program paused pending strategic review.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.